Xylem Inc. $XYL Stock: Brookmont Capital Management Raises Position

Key Points

• Brookmont Capital Management more than doubled its Xylem position in the third quarter, purchasing 14,904 additional shares for a total of 28,999 shares valued at approximately $2.94 million. Institutional investors and hedge funds own 87.96% of Xylem.
• Xylem reported quarterly earnings of $1.46 per share, exceeding the $1.34 consensus estimate, while revenue reached $2.34 billion, up 1.5% year over year. The company reaffirmed fiscal 2026 EPS guidance of $5.55–$5.70.
• Analyst sentiment is moderately positive, with an average rating of “Moderate Buy” and a consensus price target of $140.85 versus the stock’s reported price of $108.86. Xylem also pays a quarterly dividend of $0.43 per share, yielding about 1.6% annually.

Brookmont Capital Management lifted its position in Xylem Inc. (NYSE:XYL - Free Report) by 105.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 28,999 shares of the industrial products company's stock after buying an additional 14,904 shares during the quarter. Xylem comprises 1.7% of Brookmont Capital Management's investment portfolio, making the stock its 20th largest holding. Brookmont Capital Management's holdings in Xylem were worth $2,937,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. BlackRock Inc. bought a new position in shares of Xylem in the 2nd quarter valued at approximately $2,959,730,000. State Street Corp lifted its position in shares of Xylem by 2.4% during the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock worth $1,352,874,000 after purchasing an additional 270,972 shares during the last quarter. XXEC Inc. acquired a new position in shares of Xylem during the 2nd quarter worth about $850,841,000. Swedbank AB grew its holdings in Xylem by 0.3% in the 1st quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company's stock valued at $660,444,000 after buying an additional 18,759 shares during the last quarter. Finally, Royal Bank of Canada increased its position in Xylem by 1.1% in the 1st quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company's stock worth $569,207,000 after buying an additional 53,210 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Stock Performance

XYL opened at $108.86 on Friday. The stock has a market cap of $25.42 billion, a PE ratio of 25.92, a P/E/G ratio of 1.75 and a beta of 1.00. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23. Xylem Inc. has a 1 year low of $98.58 and a 1 year high of $154.27. The stock's 50 day simple moving average is $106.94 and its 200-day simple moving average is $113.43.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The firm had revenue of $2.34 billion during the quarter, compared to analysts' expectations of $2.34 billion. During the same quarter last year, the company earned $1.26 earnings per share. The company's revenue for the quarter was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Sell-side analysts forecast that Xylem Inc. will post 5.65 EPS for the current year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were issued a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. Xylem's dividend payout ratio (DPR) is presently 40.95%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Jefferies Financial Group upped their price target on Xylem from $145.00 to $150.00 and gave the stock a "buy" rating in a report on Monday, August 24th. UBS Group lowered their price objective on shares of Xylem from $138.00 to $112.00 and set a "neutral" rating on the stock in a research note on Monday, October 5th. Royal Bank Of Canada dropped their target price on shares of Xylem from $164.00 to $135.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 14th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Xylem in a research report on Wednesday, August 5th. Finally, Stifel Nicolaus set a $141.00 target price on shares of Xylem in a research note on Monday, October 19th. Eight equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $140.85.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.